ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
64 128,45
1,97%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lixte Biotechnology Holdings Inc (LIXT)

  7. Lixte Biotechnology Holdings Inc (LIXT) Actualités

LIXT Lixte Biotechnology Holdings Inc

2,82
-0,0621 (-2,15%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Lixte Biotechnology Holdings Inc LIXT NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0621 -2,15% 2,82 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,00 2,8735 3,002 2,89 2,8821
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202421:25APSMixed Shelf Filing Gives Micro Cap Delayed Boost
27/3/202420:35APSBiotech Steals The Show Following Pre-Clinical Data..
27/3/202413:30GLOBENEW SCIENTIFIC PUBLICATION SHOWS LB-100, LIXTE’S LEAD..
21/3/202413:30GLOBELIXTE Provides Update on Progress with LB-100 as a PP2A..
27/2/202422:59EDGAR2Form 8-K - Current report
27/2/202414:30GLOBEProfessor René Bernards to Present New Pre-Clinical Data on..
26/2/202416:48EDGAR2Form 8-K - Current report
26/2/202414:30GLOBELIXTE Biotechnology Enters into Exclusive Immune Oncology..
29/1/202414:30GLOBEFirst Patient Dosed with LIXTE’s LB-100 and GSK’s..
28/11/202323:21EDGAR2Form 8-K - Current report
13/11/202320:28EDGAR2Form 8-K - Current report
13/11/202314:30GLOBELIXTE Biotechnology Provides Update on Clinical Progress and..
09/11/202323:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/10/202323:27EDGAR2Form 8-K - Current report
16/10/202320:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202314:30GLOBELIXTE, Netherlands Cancer Institute, and Oncode Institute to..
10/10/202321:55EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/10/202321:47EDGAR2Form DEF 14A - Other definitive proxy statements
09/10/202314:30GLOBELIXTE Biotechnology Holdings Announces the Passing of its..
06/10/202302:39EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
06/10/202302:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/10/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
27/9/202312:15EDGAR2Form 8-K - Current report
27/9/202312:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202314:30GLOBELIXTE Appoints Bas van der Baan as President and Chief..
20/9/202317:20EDGAR2Form 8-K - Current report
20/9/202314:30GLOBELIXTE Biotechnology Announces a Supported Collaborative..
11/8/202322:20EDGAR2Form S-3 - Registration statement under Securities Act of..
09/8/202314:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21/7/202322:05EDGAR2Form 8-K - Current report
20/7/202322:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
20/7/202322:05GLOBELIXTE Biotechnology Announces Closing of $3.5 Million..
20/7/202317:45EDGAR2Form 8-K - Current report
18/7/202314:00GLOBELIXTE Biotechnology Announces Pricing of $3.5 Million..
17/7/202314:30GLOBEPreclinical Results of LIXTE Biotechnology’s Collaboration..
07/7/202320:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202316:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202316:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/7/202316:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/6/202314:30GLOBELIXTE Biotechnology Holdings, Inc. Regains Compliance with..
07/6/202314:30GLOBELIXTE Biotechnology and the Spanish Sarcoma Group Enroll..
02/6/202318:30GLOBELIXTE Biotechnology Holdings, Inc. Announces 1-for-10..
30/5/202314:30GLOBERecently Published Independent Research Reveals New..

Dernières Valeurs Consultées

NASDAQ
LIXT
Lixte Biotechnology
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés